Degenerative Disc Disease

Degenerative disc disease (DDD) is the aging process of intervertebral discs characterized by proteoglycan loss, dehydration, and annular tears. It presents as mechanical, flexion-aggravated axial back pain. MRI shows Modic changes (Type I = inflammation, Type II = fatty degeneration, Type III = sclerosis). Critical principle: imaging must correlate with concordant clinical pain - treating MRI findings alone leads to poor outcomes. Conservative management for 6-12 months is first-line. Surgery (fusion or arthroplasty) is reserved for single-level disease with intractable symptoms and positive provocative discography.

Degenerative Disc Disease (DDD) is a clinical syndrome characterized by pain and dysfunction stemming from the natural aging process of the intervertebral disc. It represents a continuum from physiological aging to pathological condition. The distinction between "aging" and "disease" is defined by the presence of symptoms, disproportionate loss of function, and quality of life impact.

Epidemiology

Prevalence

• Degeneration is ubiquitous with age. It is present in:
  • 37% of asymptomatic 20-year-olds
  • 80% of asymptomatic 50-year-olds
  • 96% of asymptomatic 80-year-olds
• Symptomatic DDD is less common but is a leading cause of disability worldwide. Back pain is the single leading cause of disability globally.
• Genetic Influence: Genetics is the strongest predictor (70% heritability) of disc degeneration, far outweighing occupational factors. Key genes include Vitamin D receptor, Aggrecan, and Collagen IX polymorphisms.

Risk Factors

• Non-Modifiable: Genetics (Twin studies show strong concordance), Age.
• Modifiable:
  • Smoking: Critically important. Nicotine inhibits chondrocyte proliferation and causes vasoconstriction of the subchondral vascular network, starving the disc.
  • Obesity: Increases mechanical load and creates a systemic pro-inflammatory state.
  • Occupation: Long-term whole-body vibration (truck driving) and heavy lifting.
  • Diabetes: Microvascular disease impairs endplate nutrition.

Natural History

• The condition typically runs a relapsing-remitting course.
• There is a tendency for pain to improve over decades as the spine proceeds to the "Stabilization" phase (stiffening/restabilization).
• Exam Pearl: Elderly patients often have less back pain but signs of stenosis (neurogenic claudication) due to osteophytes.

Anatomy of the Disc

The intervertebral disc is the largest avascular structure in the body, relying on diffusion for nutrition.

1. Nucleus Pulposus (NP):
   • Central, gelatinous core.
   • Composed of Type II Collagen and Proteoglycans (Aggrecan).
   • Aggrecan is highly hydrophilic. The high water content (80% in youth) creates hydrostatic pressure to resist axial compression and distribute load.
2. Annulus Fibrosus (AF):
   • Peripheral, tough outer ring arranged in lamellar sheets.
   • Type I Collagen dominates (tensile strength).
   • Contains the nucleus and attaches to vertebral endplates via Sharpey's fibers.
3. Vertebral Endplate:
   • Hyaline cartilage interface between disc and bone.
   • Critical for nutrition: Glucose and oxygen diffuse from vertebral body marrow capillaries through the endplate to the disc cells. Sclerosis of the endplate blocks this supply.
   • Nutritional Failure: This is the 'Final Common Pathway' of degeneration. Factors impeding marrow diffusion include atherosclerosis, smoking (vasoconstriction), and vibration.

Disc Innervation

The sinuvertebral nerve (recurrent meningeal nerve) supplies the posterior longitudinal ligament and the outer 1/3 of the annulus fibrosus.

• Neoneurogenesis: In healthy discs, the inner annulus and nucleus are aneural. In painful DDD, nerve fibers accompanied by blood vessels (neovascularization) grow deep into the nucleus.
• Mechanism: This ingrowth is driven by Neurotrophins (NGF, BDNF) expressed by degenerative chondrocytes. This explains how a deeper structure can become the source of significant pain.

Biochemical Changes

Degeneration involves a shift from anabolic (building) to catabolic (breaking) metabolism:

• Proteoglycan Loss: Decreased aggrecan synthesis and fragmentation leads to reduced water-binding capacity. The nucleus loses turgor and height.
• Collagen Switch: Shift from Type II (cartilage-like) to Type I (fibrotic) collagen in the nucleus. The distinction between nucleus and annulus blurs.
• Enzymatic Degradation: Upregulation of MMPs (Matrix Metalloproteinases) and ADAMTS enzymes digests the matrix.
• Inflammation: Release of pro-inflammatory cytokines (TNF-alpha, IL-1beta, IL-6) from the degenerating nucleus can sensitize nerve endings (sinuvertebral nerve) in the outer annulus, causing pain even without compression.

The Kirkaldy-Willis Cascade

A classic three-stage model of spinal degeneration:

History

Cardinal Feature: Axial Low Back Pain (Midline).

• Nature: Deep, aching, dull. Quality can be severe ("toothache in the back"). Contrast this with sharp, electric radicular pain.
• Aggravating Factors (Loading):
  • Flexion: Sitting, bending forward (increases intradiscal pressure).
  • Axial Load: Lifting, standing static for long periods.
  • Valsalva: Coughing/sneezing (increases intrathecal pressure - caution: also herniation feature).
• Relieving Factors (Unloading):
  • Extension, lying supine, walking.
• Pattern:
  • Often intermittent "flare-ups" lasting weeks, settling to baseline.
  • Stiffness in mornings (gel phenomenon) lasting minutes.
• Biopsychosocial Factors: Screen for "Yellow Flags" (fear avoidance, catastrophizing, depression) as these are stronger predictors of disability than MRI findings.

Red Flags (Rule Out):

• Weight loss, night pain, history of cancer (Malignancy).
• Fever, IVDU, immunosuppression (Infection).
• Significant trauma (Fracture).
• Saddle anaesthesia, bladder dysfunction (Cauda Equina Syndrome).

Physical Examination

Findings in pure DDD are often non-specific. The exam is used to rule out other pathology (hips, roots).

• Inspection: Loss of lordosis (flat back) due to muscle spasm/guarding. Lateral shift (list).
• Palpation: Midline tenderness (spinous processes/interspinous). Paraspinal muscle spasm ("washboarding").
• Range of Motion:
  • Flexion often limited and painful ("fingertip to floor" distance).
  • Extension may be preserved (unless Facet Arthropathy present).
  • Catching or "painful arc" during return from flexion suggests instability.
• Neurology:
  • Usually normal in isolated DDD.
  • Check for concordant radiculopathy (requires nerve root compression).
• Provocative Tests:
  • Disc Loading: Axial compression may reproduce back pain.
  • Straight Leg Raise: Usually negative in pure discogenic pain (unless HNP present).

Back pain is a symptom with many causes. Differentiating "Mechanical" from "Non-Mechanical" is key.

1. Mechanical Back Pain

• Facet Joint Arthropathy: Worse with extension/rotation. Paramedian tenderness.
• Spondylolisthesis: Instability pain, "step-off" on exam.
• Lumbar Strain: Acute muscle injury, self-limiting.
• Sacroiliac Joint Dysfunction: Pain below L5, Fortin's finger test positive, Patrick's FABER test.

2. Non-Mechanical Assessment

• Tumour: Multiple Myeloma, Metastases (Breast, Lung, Prostate, Kidney, Thyroid). Night pain.
• Infection: Discitis/Osteomyelitis. Fever, unremitting pain. Modic I changes can mimic infection.
• Inflammatory: Ankylosing Spondylitis. Morning stiffness greater than 30 mins, young male, bamboo spine.

3. Visceral Referral

• AAA: Pulsatile mass, cardiovascular risk factors.
• Renal: Kidney stones (colic), Pyelonephritis (fever/CVA tenderness).
• Pancreatitis: Penetrating back pain.

Imaging

1. Plain Radiographs (X-ray)

• AP/Lateral: Assess alignment (Scoliosis, Lordosis).
• Findings:
  • Loss of disc height (vacuum phenomenon).
  • Endplate sclerosis.
  • Vacuum phenomenon (nitrogen gas in clefts - sign of instability).
  • Osteophytes (traction spurs).
• Flexion/Extension Views: Critical to rule out instability (Spondylolisthesis) prior to fusion surgery. (translation greater than 3mm or angulation greater than 10 degrees).

2. MRI (Gold Standard)

• T2 Sagittal: Best for hydration status (Pfirrmann grade).
• High Intensity Zone (HIZ): Bright spot in posterior annulus on T2. Correlates with annular tear. High specificity for discogenic pain (but controversial).
• Modic Changes: Endplate signal abnormalities.
• Features: "Black Disc", loss of height, bulging, nerve root compression.

3. Discography (Provocative)

• Injection of contrast/saline into disc nucleus under fluoroscopy.
• Positive Test: Reproduction of patient's exact familiar pain (concordant pain) + Morphological degeneration + Negative control level.
• Current Status: Highly controversial. High false-positive rate. Risk of damaging healthy discs (accelerated degeneration). Used rarely for indeterminate cases prior to fusion.
• Nuclear Medicine: SPECT-CT may show "hot" uptake at active degenerative levels, aiding localization.

Imaging Examples

View larger

View larger

View larger

Surgical Complications

1. General Spinal Surgery risks:

• Infection (1-3%).
• Dural tear (CSF leak).
• Nerve root injury.
• DVT/PE.

2. Fusion Specific:

• Pseudarthrosis (Non-union): Failure of bone to fuse. Risk factors: Smoking, NSAIDs, Diabetes. Causes persistent pain leading to Revision.
• Adjacent Segment Disease (ASD): Accelerated degeneration at levels above/below fusion due to increased stress. Rate: 2-3% per year.
• Hardware Failure: Screw loosening, cage migration.

3. Arthroplasty Specific:

• Implant migration/subsidence.
• Heterotopic ossification (auto-fusion).
• Polyethylene wear debris (rare).
• Difficulty of revision (anterior approach scar tissue - "vascular disaster" risk on revision).

4. Anterior Approach Risks (ALIF/TDR):

• Vascular Injury: Iliac vein/artery (life-threatening).
• Retrograde Ejaculation: Injury to Superior Hypogastric Plexus (males). Rate 1-5%.
• Ureteral Injury: Rare.

• Natural History: Favorable. Many patients stabilize ("burn out") as the spine stiffens.
• Conservative Care: Good function executable for most.
• Fusion Results:
  • Pain reduction: Typically 50-70% reduction (not 100%).
  • Return to work: Variable.
  • Satisfaction: 60-75% in well-selected patients.
• Predictors of Poor Outcome:
  • Psychosocial factors (Yellow flags, Workers Comp, Depression).
  • Smoking.
  • Obesity.
  • Multi-level disease.

Global Epidemiology

• Low back pain is the single leading cause of years lived with disability worldwide (Global Burden of Disease).
• Disc degeneration on imaging rises with age (37% at 20 years to 96% at 80 years; Brinjikji 2015) and is largely asymptomatic - prevalence is similar across populations, so it is a global aging phenomenon rather than a regional disease.
• Genetics carries the strongest weight in heritability studies, outweighing occupational mechanical load.

Society Guidance (Side by Side)

Consistent global message: at least 3-6 months (commonly up to 12) of structured non-operative care; never operate on imaging alone; document concordant clinical correlation before any fusion or arthroplasty.

Registry & Outcome Notes

• Spine procedures are tracked in national registries such as the British Spine Registry, Swespine (Sweden) and the Norwegian (NORspine) registry. Registry data consistently show smaller, more variable benefit for fusion in pure axial discogenic pain than for radiculopathy or deformity.
• Adjacent segment disease accrues at roughly 2-3% per year after lumbar fusion in registry and cohort follow-up.

High- vs Limited-Resource Variation

• High-resource settings: ready MRI access (with attendant risk of over-imaging), multidisciplinary pain programmes, and access to arthroplasty implants.
• Limited-resource settings: emphasis on clinical diagnosis, exercise and analgesia; imaging and instrumented surgery rationed to red-flag or instability cases. Across all settings the core principle is unchanged: conservative-first, image only to change management, operate only on concordant refractory disease.

1. Fritzell P, Hagg O, Wessberg P, Nordwall A. 2001 Volvo Award Winner in Clinical Studies: Lumbar fusion versus nonsurgical treatment for chronic low back pain: a multicenter randomized controlled trial from the Swedish Lumbar Spine Study Group. Spine. 2001;26:2521-2532.
2. Brinjikji W, Luetmer PH, Comstock B, et al. Systematic literature review of imaging features of spinal degeneration in asymptomatic populations. AJNR Am J Neuroradiol. 2015;36(4):811-6.
3. Modic MT, Steinberg PM, Ross JS, et al. Degenerative disk disease: assessment of changes in vertebral body marrow with MR imaging. Radiology. 1988;166:193-199.
4. Kirkaldy-Willis WH, Farfan HF. Instability of the lumbar spine. Clin Orthop Relat Res. 1982;(165):110-23.
5. Zigler J, Delamarter R, Spivak JM, et al. Results of the prospective, randomized, multicenter Food and Drug Administration investigational device exemption study of the ProDisc-L total disc replacement versus circumferential fusion for the treatment of 1-level degenerative disc disease. Spine. 2007;32:1155-1162.